David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Rogers Communications
RCI
$19.7B
| $16.8M | 0.03% |
325,721
+135,163
| +71% | +$6.91M |
|
677
BorgWarner
BWA
$13.1B
| $16.8M | 0.03% |
+372,288
| New | +$15.2M |
|
|
CLVS
678
DELISTED
Clovis Oncology, Inc.
CLVS
| $16.7M | 0.03% |
202,412
-877,319
| -81% | -$69.6M |
|
|
WMGI
679
DELISTED
Wright Medical Group Inc
WMGI
| $16.7M | 0.03% |
644,663
+74,103
| +13% | +$2.04M |
|
680
PUT
Ralph Lauren
RL
$22.1B
| $16.6M | 0.03% |
188,000
| – | – |
|
681
Deere & Co
DE
$175B
| $16.6M | 0.03% |
132,105
-8,870
| -6% | -$1.09M |
|
|
HMSY
682
DELISTED
HMS Holdings Corp.
HMSY
| $16.5M | 0.03% |
832,917
+38,045
| +5% | +$707K |
|
|
VISN
683
Vistance Networks Inc
VISN
$2.5B
| $16.5M | 0.03% |
497,316
-462,647
| -48% | -$15.8M |
|
|
SBNY
684
DELISTED
Signature Bank
SBNY
| $16.5M | 0.03% |
128,786
+92,835
| +258% | +$12.2M |
|
|
BWLD
685
PUT
DELISTED
Buffalo Wild Wings, Inc.
BWLD
| $16.5M | 0.03% |
155,700
+85,700
| +122% | +$9.53M |
|
686
CALL
GE Aerospace
GE
$355B
| $16.4M | 0.03% |
+141,890
| New | +$17.2M |
|
|
NVO
687
Novo Nordisk
NVO
$207B
| $16.4M | 0.03% |
681,018
+646,998
| +1,902% | +$14.6M |
|
688
CALL
Lockheed Martin
LMT
$130B
| $16.4M | 0.03% |
52,800
-68,500
| -56% | -$20.4M |
|
689
Louisiana-Pacific
LPX
$5.08B
| $16.3M | 0.03% |
601,927
-181,530
| -23% | -$4.63M |
|
|
ATHN
690
DELISTED
Athenahealth, Inc.
ATHN
| $16.3M | 0.03% |
131,033
-24,045
| -16% | -$3.31M |
|
|
ALXN
691
DELISTED
Alexion Pharmaceuticals
ALXN
| $16.2M | 0.03% |
115,759
-173,825
| -60% | -$23.6M |
|
|
SWN
692
DELISTED
Southwestern Energy Company
SWN
| $16.2M | 0.02% |
2,657,694
-4,933,944
| -65% | -$28M |
|
|
HPP
693
Hudson Pacific Properties
HPP
$798M
| $16.2M | 0.02% |
69,117
+1,241
| +2% | +$283K |
|
694
GameStop
GME
$8.09B
| $16.2M | 0.02% |
3,140,712
+480,012
| +18% | +$2.49M |
|
695
Illumina
ILMN
$33.7B
| $16.2M | 0.02% |
83,447
+79,176
| +1,854% | +$14.7M |
|
|
XYZ
696
PUT
Block Inc
XYZ
$48.9B
| $16.1M | 0.02% |
560,000
+380,000
| +211% | +$9.95M |
|
697
CALL
American Airlines Group
AAL
$9.02B
| $16.1M | 0.02% |
339,000
-259,300
| -43% | -$12.5M |
|
698
McCormick & Company Non-Voting
MKC
$15.1B
| $16.1M | 0.02% |
312,942
+154,732
| +98% | +$7.46M |
|
699
Centene
CNC
$32.4B
| $16M | 0.02% |
330,768
-64,212
| -16% | -$2.76M |
|
700
ON Semiconductor
ON
$28B
| $16M | 0.02% |
864,433
+46,411
| +6% | +$747K |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.